Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents. (Record no. 29864630)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01781 a2200541 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518045918.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202005s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1750-7448 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.2217/imt-2019-0057 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Suez, Daniel |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200525 |
| 245 00 - TITLE STATEMENT | |
| Title | Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Immunotherapy |
| Date of publication, distribution, etc. | 08 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1057-1065 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Child |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Child, Preschool |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug-Related Side Effects and Adverse Reactions |
| General subdivision | epidemiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Europe |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunoglobulin G |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Injections, Subcutaneous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | North America |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Primary Immunodeficiency Diseases |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kriván, Gergely |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jolles, Stephen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stein, Mark |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gupta, Sudhir |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Paris, Kenneth |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Hagen, P Martin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brodszki, Nicholas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Engl, Werner |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Leibl, Heinz |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McCoy, Barbara |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yel, Leman |
| 773 0# - HOST ITEM ENTRY | |
| Title | Immunotherapy |
| Related parts | vol. 11 |
| -- | no. 12 |
| -- | p. 1057-1065 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.2217/imt-2019-0057">https://doi.org/10.2217/imt-2019-0057</a> |
| Public note | Available from publisher's website |
No items available.